Bone marrow MSC |
– |
miR-182-5p |
Intravenous |
30-min LAD occlusion and reperfusion, mouse |
[93] |
Human umbilical cord MSC |
AT-EHBPE/CP05 peptide hydrogel |
Not analyzed |
intramyocardial |
90-min LAD occlusion, mouse |
[109] |
Human cardiosphere-derived cell |
– |
Not analyzed |
intracoronary + intramyocardial |
90-min LAD occlusion and 30-min reperfusion, pig |
[106] |
Human cardiosphere |
conjugated with cardiac homing peptide |
miR21, miR146a |
Intravenous |
30-min LAD occlusion, mouse |
[100] |
M2 macrophage |
– |
Not analyzed |
Intravenous; tail vein |
30-min LAD occlusion and 2 h reperfusion, rat |
[110] |
Human neuronal stem cell |
– |
Not analyzed |
Intravenous; jugular vein |
40-min LAD occlusion and 2 h reperfusion, mouse |
[111] |
Cortical bone stem cell |
– |
miR-378a, let-7a-3, and miR-31 |
intramuscular |
45-min left coronary artery ligation and reperfusion, mouse |
[112] |
Mouse adipose-derived MSC |
– |
miR-224-5p |
Intravenous; tail vein |
30-min left coronary artery (LCA) ligation and reperfusion, mouse |
[91] |
Myocardial fibroblasts |
– |
miR-133a |
intramyocardial |
30-min LCA ligation and 120-min reperfusion, rat |
[113] |
Remote ischemic preconditioning plasma |
– |
miR-24 |
intramyocardial immediately after ligation |
45-min LAD occlusion and 24 h reperfusion, rat |
[114] |
Human plasma |
– |
miR-486 |
intraperitoneally after ligation |
30-min LAD occlusion and 24 h reperfusion, rat |
[115] |
Adult rats and human blood |
– |
HSP70 |
Intravenous; tail vein |
30-min LAD occlusion and 120-min reperfusion, rat |
[116] |
C57BL/6 mouse MSC |
– |
miR-21-5p |
intramyocardial |
45-min LAD occlusion and reperfusion, mouse |
[117] |
Human embryonic stem cell-derived MSC |
– |
Not analyzed |
Intravenous of CM before reperfusion; tail vein |
30-min LCA ligation and 24 h reperfusion, mouse |
[98] |